Ascend Wellness Holdings (AAWH) Operating Income (2020 - 2026)
Ascend Wellness Holdings (AAWH) posted quarterly Operating Income of $2.5 million for Q1 2026, up 2.41% year-over-year from $2.5 million in Q1 2025, and up 114.83% quarter-over-quarter from -$17.2 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Operating Income (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Operating Income history runs 7 years deep, the most recent figure standing at $2.5 million for Q1 2026.
- In Q1 2026, Operating Income rose 2.41% year-over-year to $2.5 million; the TTM figure through Mar 2026 stood at -$17.0 million (down 464.95% YoY), while the FY2025 annual figure was -$17.0 million, down 459.36% from the prior year.
- Operating Income for Q1 2026 stood at $2.5 million, up from -$17.2 million in the prior quarter.
- The five-year high for Operating Income was $6.1 million in Q4 2024, with the low at -$17.2 million in Q4 2025.
- The 5-year median for Operating Income is $255000.0 (2023), against an average of -$1.2 million.
- The sharpest annual moves came in 2023 and 2024: Operating Income slumped 1219.83% in 2023, then jumped 981.21% in 2024.
- Ascend Wellness Holdings' Operating Income stood at $5.4 million in 2022, then sank by 89.52% to $564000.0 in 2023, then surged by 981.21% to $6.1 million in 2024, then plunged by 381.58% to -$17.2 million in 2025, then soared by 114.83% to $2.5 million in 2026.
- Business Quant data shows AAWH's Operating Income at $2.5 million in Q1 2026, -$17.2 million in Q4 2025, and -$1.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Ascend Wellness Holdings | 83.23 Mn | 16.23 Mn | 45.49 Mn | 5.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.28 Mn |
| Mar 31, 2026 | 2.55 Mn |
| Dec 31, 2025 | -17.17 Mn |
| Sep 30, 2025 | -1.33 Mn |
| Jun 30, 2025 | -1.00 Mn |
| Mar 31, 2025 | 2.49 Mn |
| Dec 31, 2024 | 6.10 Mn |
| Sep 30, 2024 | -2.42 Mn |
| Jun 30, 2024 | -1.52 Mn |
| Mar 31, 2024 | 2.58 Mn |
| Dec 31, 2023 | 564,000.00 |
| Sep 30, 2023 | 3.55 Mn |
| Jun 30, 2023 | -7.99 Mn |
| Mar 31, 2023 | 255,000.00 |
| Dec 31, 2022 | 5.38 Mn |
| Sep 30, 2022 | 2.48 Mn |
| Jun 30, 2022 | -605,000.00 |
| Mar 31, 2022 | -14.78 Mn |
| Dec 31, 2021 | -731,000.00 |
| Sep 30, 2021 | 11.61 Mn |